chr16-20348594-G-A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003361.4(UMOD):c.707C>T(p.Pro236Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000695 in 1,439,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P236Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003361.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UMOD | NM_003361.4 | c.707C>T | p.Pro236Leu | missense_variant | 3/11 | ENST00000396138.9 | NP_003352.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UMOD | ENST00000396138.9 | c.707C>T | p.Pro236Leu | missense_variant | 3/11 | 5 | NM_003361.4 | ENSP00000379442 | P2 | |
UMOD | ENST00000396134.6 | c.806C>T | p.Pro269Leu | missense_variant | 4/12 | 2 | ENSP00000379438 | A2 | ||
UMOD | ENST00000570689.5 | c.707C>T | p.Pro236Leu | missense_variant | 3/11 | 5 | ENSP00000460548 | P2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000481 AC: 1AN: 207972Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 114752
GnomAD4 exome AF: 6.95e-7 AC: 1AN: 1439028Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 715052
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2017 | - - |
Familial juvenile hyperuricemic nephropathy type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 12, 2021 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
UMOD-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 08, 2023 | The UMOD c.707C>T variant is predicted to result in the amino acid substitution p.Pro236Leu. This variant was reported in multiple unrelated individuals with juvenile hyperuricemic nephropathy, (Kudo et al. 2004. PubMed ID: 15086896; Bollée et al. 2011. PubMed ID: 21868615; Hureaux et al. 2019. PubMed ID: 31672324; Olinger et al. 2020. PubMed ID: 32450155). This variant is reported in 0.0011% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-20359916-G-A). This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at